Danaher lands in the Bahamas the week its new subsidiary closes

Danaher Corporation flew from New York Stewart International Airport to Leonard M. Thompson International Airport in Marsh Harbour, the Bahamas, on June 19, 2026, aboard its Dassault Falcon 900B (tail N886DC). The two-hour, 30-minute hop from the mainland to the Abaco Islands is a familiar route for the Washington, D.C.-based diagnostics and life-sciences holding company.

The same week Danaher’s N886DC touched down in the Bahamas, Danaher completed its acquisition of Masimo Corporation, a pulse oximetry and patient monitoring firm based in Irvine, California. The deal, announced in February and finalized on June 10, 2026, was valued at approximately $10 billion, per a company press release. Masimo now operates as a wholly-owned subsidiary within Danaher’s Diagnostics segment, alongside Cepheid, Beckman Coulter, and Leica. The trip to Marsh Harbour — a known destination for Danaher leadership — comes as the company integrates its newest unit and continues to deploy diagnostic tools for public health responses, including Ebola testing via its Cepheid subsidiary.

Danaher’s recent flight patterns show a steady rhythm between its Dulles-area base and destinations like Chicago, San Francisco, and the Bahamas. The June 19 trip follows a series of flights from Colorado and New York, suggesting a period of board-level or operational review. With Masimo’s stock delisted from the Nasdaq and its leadership now reporting into Danaher’s diagnostics division, the Bahamas trip likely doubles as a working retreat and a quiet moment to assess the newly expanded portfolio.